8-K: Allied Corp. Completes First Shipment to Portugal, Initiating UK Supply Contract

Allied Corp. has successfully shipped 30kg of medical cannabis to its Portuguese partner, marking the start of a UK supply contract expected to generate at least $360,000 in annual revenue.

Summary

• Allied Corp., a Canadian medical cannabis supplier, has completed a 30kg shipment of THC-based medical cannabis to Blossom Pharmaceuticals in Portugal.
• This shipment is the first step in fulfilling a 3-year supply contract with a UK distributor, which is expected to generate at least $360,000 in annual revenue starting in Q1 2025.
• The medical cannabis is manufactured with EU-GMP certification, which is required for import into several European countries.
• This follows a previous 180kg purchase order delivered in May.
• Allied also has an exclusive forward purchase agreement with Canpoland for 1.05 tons of cannabis per year, worth EUR 15.3 million over 5 years.

Sentiment

Score: 8

Explanation: The document is positive, highlighting successful shipments and a new supply contract with clear revenue expectations. The company is demonstrating its ability to operate in a complex market and secure significant deals.

Positives

• The successful shipment to Portugal demonstrates Allied's ability to operate in highly regulated markets.
• The UK supply contract provides a clear revenue stream for the company.
• The EU-GMP certification allows Allied to access multiple European markets.
• The forward purchase agreement with Canpoland secures a significant volume of sales over the next 5 years.
• Allied is demonstrating its ability to be a reliable partner in the complex cannabis supply chain.

Risks

• The cannabis industry is subject to regulatory risks and market changes.
• There are risks related to competition within the cannabis and medical industries.
• Operational and logistical challenges could impact the company's performance.
• Market demand and economic conditions could affect growth and profitability.
• Potential delays or adverse changes in project locations or expansion plans could occur.

Future Outlook

Allied Corp. anticipates continued growth in European cannabis markets and aims to execute existing supply agreements. The company also plans to expand its operations in Colombia, Kelowna, and Nevada.

Management Comments

• Michael Moses, Chief Business Development Officer, stated that the shipment to Blossom marks the first step in fulfilling the UK supply contract.
• Management believes that Allied is demonstrating its ability to be a reliable partner in the complex cannabis supply chain.

Industry Context

This announcement highlights the growing international trade in medical cannabis, particularly in Europe, where demand is increasing and regulations are becoming more defined. Allied's focus on EU-GMP certification positions them well to compete in this market.

Comparison to Industry Standards

• The EU-GMP certification is a key requirement for exporting medical cannabis to many European countries, putting Allied in line with industry best practices.
• The minimum volume requirements of 200kg per year for the UK contract are typical for supply agreements in the medical cannabis sector.
• The forward purchase agreement with Canpoland for 1.05 tons per year is a significant commitment, indicating a strong market demand for Allied's product.
• Companies like Aurora Cannabis and Tilray have also focused on securing EU-GMP certifications and supply agreements in Europe, making Allied's strategy comparable to industry leaders.

Stakeholder Impact

• Shareholders will likely view the news positively due to the new revenue stream and market expansion.
• Employees may benefit from the company's growth and increased stability.
• Customers in the UK and Poland will gain access to Allied's medical cannabis products.
• Suppliers may see increased demand for their products and services.

Next Steps

• Allied Corp. will continue to fulfill the UK supply contract.
• The company will continue to execute its forward purchase agreement with Canpoland.
• Allied will continue to expand its operations in Colombia, Kelowna, and Nevada.

Key Dates

Keywords

medical cannabis, EU-GMP, supply contract, Portugal, United Kingdom, Blossom Pharmaceuticals, Canpoland, THC, cannabis, OTCQB